Hypertension
Not recruitingStudy on Baxdrostat for Lowering Blood Pressure in Patients with Resistant Hypertension
- Disease:Hypertension
- Substances:Baxdrostat
Germany- Participants:18–64 years · 65+ years
- Substances:Baxdrostat
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Germany79 clinical trials in Erfurt, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on various cancer types including non-small cell lung cancer, breast cancer, and melanoma. Research evaluates innovative treatment combinations and immunotherapy approaches.
Multiple trials investigating combination therapies and immunological approaches for improved patient outcomes.
Innovative research targeting atherosclerotic cardiovascular disease and hypercholesterolemia. Studies focus on new therapeutic approaches for managing cholesterol levels and reducing cardiovascular risks.
Trials evaluating novel medications for better management of cardiovascular conditions.
Comprehensive studies on blood-related conditions including acute lymphoblastic leukemia and multiple myeloma. Focus on developing effective treatments for both pediatric and adult patients.
Advanced treatment protocols combining established and innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.